[{"address1": "200 Pine Street", "address2": "Suite 400", "city": "San Francisco", "state": "CA", "zip": "94104", "country": "United States", "phone": "415 371 8300", "website": "https://jaguar.health", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company offers Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa A. Conte", "age": 65, "title": "Founder, CEO, President & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 693865, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pravin R. Chaturvedi Ph.D.", "age": 61, "title": "Chief Scientific Officer & Chair of Scientific Advisory Board", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 592507, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven R. King Ph.D.", "age": 66, "title": "Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 461782, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carol R. Lizak M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hodge", "title": "Senior Director of Investor Relations, Business Development & Special Events", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen J. Brunke Ph.D.", "age": 71, "title": "Executive VP of Corporate & Business Development", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Sesin Ph.D.", "title": "Chief Manufacturing Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian H. Wendt M.B.A.", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 441310, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Massimo  Radaelli M.B.A., Ph.D.", "age": 66, "title": "President of Jaguar International", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine Miller Collis", "title": "Senior Vice President of Growth Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.04, "open": 2.0, "dayLow": 1.9301, "dayHigh": 2.01, "regularMarketPreviousClose": 2.04, "regularMarketOpen": 2.0, "regularMarketDayLow": 1.9301, "regularMarketDayHigh": 2.01, "payoutRatio": 0.0, "beta": 0.58, "forwardPE": -0.75862074, "volume": 41049, "regularMarketVolume": 41049, "averageVolume": 97767, "averageVolume10days": 79950, "averageDailyVolume10Day": 79950, "bid": 1.94, "ask": 2.03, "bidSize": 1, "askSize": 1, "marketCap": 3790571, "fiftyTwoWeekLow": 1.93, "fiftyTwoWeekHigh": 35.25, "priceToSalesTrailing12Months": 0.32813114, "fiftyDayAverage": 3.0763, "twoHundredDayAverage": 14.52058, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 36195328, "profitMargins": 0.0, "floatShares": 915230, "sharesOutstanding": 1914430, "sharesShort": 39637, "sharesShortPriorMonth": 34177, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0299, "heldPercentInsiders": 0.081499994, "heldPercentInstitutions": 0.04553, "shortRatio": 0.4, "shortPercentOfFloat": 0.0306, "impliedSharesOutstanding": 1914430, "bookValue": 2.644, "priceToBook": 0.74886537, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -39730000, "trailingEps": -60.27, "forwardEps": -2.61, "lastSplitFactor": "1:25", "lastSplitDate": 1742774400, "enterpriseToRevenue": 3.133, "enterpriseToEbitda": -1.2, "52WeekChange": -0.9292857, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 1.98, "targetHighPrice": 40.0, "targetLowPrice": 16.0, "targetMeanPrice": 28.0, "targetMedianPrice": 28.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 5690000, "totalCashPerShare": 5.587, "ebitda": -30159000, "totalDebt": 38336000, "quickRatio": 0.251, "currentRatio": 1.079, "totalRevenue": 11552000, "debtToEquity": 1156.44, "revenuePerShare": 27.199, "returnOnAssets": -0.37479, "returnOnEquity": -4.59519, "grossProfits": 9512000, "freeCashflow": -16948124, "operatingCashflow": -29653000, "revenueGrowth": -0.058, "grossMargins": 0.82341003, "ebitdaMargins": -2.61072, "operatingMargins": -4.25519, "financialCurrency": "USD", "symbol": "JAGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "shortName": "Jaguar Health, Inc.", "longName": "Jaguar Health, Inc.", "corporateActions": [], "postMarketTime": 1754087341, "regularMarketTime": 1754078401, "messageBoardId": "finmb_12827020", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.94117, "regularMarketPrice": 1.98, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1431437400000, "postMarketChangePercent": -1.0101, "postMarketPrice": 1.96, "postMarketChange": -0.01999998, "regularMarketChange": -0.0599999, "regularMarketDayRange": "1.9301 - 2.01", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 97767, "fiftyTwoWeekLowChange": 0.05000007, "fiftyTwoWeekLowChangePercent": 0.025906773, "fiftyTwoWeekRange": "1.93 - 35.25", "fiftyTwoWeekHighChange": -33.27, "fiftyTwoWeekHighChangePercent": -0.9438298, "fiftyTwoWeekChangePercent": -92.92857, "dividendDate": 1559865600, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1755115200, "earningsTimestampEnd": 1755115200, "earningsCallTimestampStart": 1747340100, "earningsCallTimestampEnd": 1747340100, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -60.27, "epsForward": -2.61, "epsCurrentYear": -23.81, "priceEpsCurrentYear": -0.08315834, "fiftyDayAverageChange": -1.0962999, "fiftyDayAverageChangePercent": -0.35636964, "twoHundredDayAverageChange": -12.540581, "twoHundredDayAverageChangePercent": -0.86364186, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "exchange": "NCM", "marketState": "CLOSED", "displayName": "Jaguar Health", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]